 |
Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017. [1]
|
Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017. [1]
Tabar took her medical degree from the American University of Beirut. It was followed by a neurosurgical residency at the University of Massachusetts. She did postdoctoral work at the National Institute of Neurological Disorders and Stroke.
Having done a research fellowship at Memorial Sloan Kettering Cancer Center, Tabar joined the faculty. At present, she is the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education. [2] In December 2017, she was named Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center, succeeding to Philip Gutin, MD. [3] [4]
Viviane Tabar is also the founding Director of the Multidisciplinary Pituitary and Skull Base Tumor Center at Memorial Sloan Kettering Cancer Center. [5]
Tabar's specialty is intraoperative brain mapping techniques.
Her research is in stem cell biology, and she is one of the leaders of the New York State consortium for the development of human embryonic stem cell–derived dopamine neurons for Parkinson's disease. [6] She has devised strategies for cell-based therapies for the repair of radiation-induced brain injury. Her lab has used pluripotent stem cells for brain tumor modeling, resulting in novel insights into the biology of gliomas and to the discovery of candidate therapeutic targets for brain tumors. She has a clinical expertise in the surgical management of brain tumors such as complex gliomas, meningiomas and skull base tumors. [7] In 2010, with her research team of the Sloan-Kettering Cancer Center, she demonstrated the fact that tumorous blood vessel cells may come from tumor cells as a way to create their own blood supply. Those results contributed to demonstrate the great plasticity of tumors. [8]
A prolific author, she has written dozens of widely cited publications.
Viviane Tabar is married to Lorenz Studer. They have two children together. [14] [11] They both work at the Sloan Kettering Institute heading medical research projects. [15]
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
A brainstem glioma is a cancerous glioma tumor in the brainstem. Around 75% are diagnosed in children and young adults under the age of twenty, but have been known to affect older adults as well. Brainstem gliomas start in the brain or spinal cord tissue and typically spread throughout the nervous system.
Alfredo Quiñones-Hinojosa is a Mexican-American neurosurgeon, author, and researcher. Currently, he is the William J. and Charles H. Mayo Professor and Chair of Neurologic Surgery and runs a basic science research lab at the Mayo Clinic Jacksonville in Florida.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.
Aaron A. Cohen-Gadol is a professor of neurological surgery in the department of neurosurgery at Indiana University School of Medicine and a neurosurgeon at Indiana University Health specializing in the surgical treatment of complex brain tumors, vascular malformations, cavernous malformations, etc. He performs removal of brain tumors via minimally invasive endoscopic techniques, which use the nasal pathways instead of opening the skull.
Marcel R.M. van den Brink is a Dutch oncologist and researcher known for his research in hematopoietic stem cell transplantation for cancer patients.
Isabelle M. Germano is a neurosurgeon and professor of neurosurgery, neurology, and oncology at the Icahn School of Medicine at Mount Sinai Hospital. She is a Fellow of the American College of Surgeons and the American Association of Neurological Surgeons. Germano works with image-guided brain and spine surgery.
Lorenz Studer is a Swiss biologist. He is the founder and director of the Center for Stem Cell Biology at Memorial-Sloan Kettering Cancer Center in New York City. He is a developmental biologist and neuroscientist who is pioneering the generation of midbrain dopamine neurons for transplantation and clinical applications. His expertise in cell engineering spans a wide range of cells/tissues within the nervous system geared toward disease modeling and exploring cell replacement therapy. Currently, he is a member of the Developmental Biology Program and Department of Neurosurgery at Memorial Sloan-Kettering Cancer Center and a Professor of Neuroscience at Weill Cornell Medical College in New York City, NY.
Luis F. Parada is a Colombian developmental biologist and neuroscientist who currently serves as Director of the Brain Tumor Center, Albert C. Foster Chair and American Cancer Society Research Professor at Memorial Sloan Kettering Cancer Center in New York City, New York.
David A. Scheinberg is an American physician, scientist, drug developer, and entrepreneur, who is currently Vincent Astor Chair, and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.
Luis Alberto Diaz, Jr. is the Head of the Division of Solid Tumor Oncology in Memorial Sloan Kettering’s Department of Medicine.
Ricardo Jorge Komotar is an American neurosurgeon who specializes in the field of brain tumors. He serves as director of the University of Miami Brain Tumor Initiative, director of the UM Neurosurgery Residency Program, and director of the UM Surgical Neurooncology Fellowship Program.
Sheila K. Singh MD, PhD, FRCSC is a chief pediatric neurosurgeon at McMaster Children's Hospital in Ontario, Canada. She is also Professor of Surgery and Biochemistry, the Division Head of Neurosurgery at Hamilton Health Sciences, the Research Director for McMaster's Division of Neurosurgery, and a scientist/principal investigator appointed to the Stem Cell and Cancer Research Institute at McMaster University.
Professor Richard James Gilbertson is a paediatric oncology clinician scientist and a Senior Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. He is the Li Ka Shing Chair of Oncology, and Director of the CRUK Cambridge Major Centre and the Children's Brain Tumour Centre of Excellence.
Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. She has published over 230 research articles and a textbook, Brain Tumor Immunotherapy. She served as editor-in-chief of the Journal of Neuro-Oncology from 2007 to 2017.
Michel Sadelain is an genetic engineer and cell therapist at Memorial Sloan Kettering Cancer Center, New York, New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and the head of the Gene Transfer and Gene Expression Laboratory. He is a member of the department of medicine at Memorial Hospital and of the immunology program at the Sloan Kettering Institute. He is best known for his major contributions to T cell engineering and chimeric antigen receptor (CAR) therapy, an immunotherapy based on the genetic engineering of a patient's own T cells to treat cancer.
Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.
Valerie W Rusch, MD, FACS, is an American thoracic surgeon who is currently the Miner Family Chair for Intrathoracic Cancers and Vice Chair for Clinical Research, Department of Surgery, at Memorial Sloan Kettering Cancer Center.
Deborah L. Benzil is an American neurosurgeon specializing in brain and spine tumors, stereotactic radiosurgery, socioeconomic education. She was awarded the Anthony Greto Fellowship from the Association of Brain Tumor Research. She is the Vice Chair and professor of neurosurgery at the Cleveland Clinic in Cleveland, Ohio, USA.
| Authority control databases: Academics |
|---|
 | This biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |
